Cogent Biosciences, Inc. (COGT)
COGT price $31.43 +0.19 +0.61%
- Ticker
- COGT
- Price
- $31.43
- Change
- +0.19 +0.61%
- Market cap
- $5.45B
- P/E
- -13.52
- Forward P/E
- 36.37
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 65
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced…